http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10324627-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5d04736b0b882a4f5a1e0e0e4cd8cbb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-62 |
| filingDate | 1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f83ab92b64382a23e06ef66699cf2d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62f4fb333a55f20f13d15bfd6d2d4b5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_832b60bb0c92634ab5efff98dfebf2a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_544671e9d353d5b3a31d05eab8835e8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c8f8de112edf10f1f3e8b6758d65cce |
| publicationDate | 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10324627-A |
| titleOfInvention | Drugs for cancer treatment |
| abstract | PROBLEM TO BE SOLVED: To provide a therapeutic agent for cancer comprising an L-ascorbic acid derivative which is stable against oxidation, has excellent absorbability to animal cells, and can efficiently increase the amount of intracellular accumulation. Of cancer and the provision of cancer treatment methods using the same. SOLUTION: When animal cells are cultured in a medium containing an ascorbic acid derivative for 20 hours, compared with a case where L-ascorbic acid-2-magnesium phosphate of 50 μm is used in the medium, the concentration in the medium is equal to or less than 5 μm. For treating cancer comprising an L-ascorbic acid derivative having an ester bond or an ether bond at the 2-position and a hydrophobic group at least at either the 5-position or the 6-position. A drug, and a drug for treating cancer comprising the L-ascorbic acid derivative and at least one antineoplastic agent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3092220-A4 |
| priorityDate | 1997-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.